Roivant Sciences Ltd (ROIV)
NASDAQ · Healthcare
Roivant Sciences Ltd Income Statement 2021–2026
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | |
|---|---|---|---|---|---|---|
| Revenues | ||||||
| Revenue | 8.3M | 29.1M | 32.7M | 31.5M | 55.3M | 23.8M |
| Gross Profit | — | — | — | — | — | — |
| Profitability | ||||||
| Operating Income | -515.1M | -1.00B | 4.50B | -906.8M | -1.35B | -1.07B |
| EBITDA | -511.7M | -989.2M | 4.52B | -887.9M | -1.35B | — |
| Net Income | -299.8M | -172.0M | 4.35B | -1.01B | -845.3M | -809.2M |
| Per Share Data | ||||||
| EPS (diluted) | $-0.54 | $-0.24 | $5.23 | $-1.42 | $-1.26 | — |
| Shares Outstanding (dil.) | 694M | 725M | 831M | 713M | 670M | 652M |
Roivant Sciences Ltd Income Statement — FAQ
Roivant Sciences Ltd (ROIV) income statement over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ROIV's income statement history?
The chart and table above show Roivant Sciences Ltd's income statement by year and by quarter, including the growth rate.